Salesforce
CRM
$170.77
-1.11%
Salesforce is a leading provider of enterprise cloud computing solutions, primarily offering customer relationship management (CRM) technology through its Customer 360 platform, which integrates sales, service, marketing, and commerce applications. As the dominant player in the global CRM market, Salesforce distinguishes itself through its comprehensive suite of cloud-based products and a strong ecosystem of partners and developers. The current investor narrative centers on the company's strategic pivot toward AI-driven capabilities and margin expansion, while facing headwinds from a rotation in enterprise tech spending away from software and toward hardware, as highlighted by recent weak guidance from IBM and a broader selloff in high-multiple tech stocks.…
CRM
Salesforce
$170.77
Related headlines
Investment Opinion: Should I buy CRM Today?
Rating: Buy. Thesis: Salesforce's deeply discounted valuation (forward PE 11.0x) combined with strong margin expansion and robust free cash flow generation creates a compelling risk/reward opportunity, despite near-term macro headwinds. The analyst consensus is Buy with an average target of $245.16, implying 43.5% upside.
Supporting Evidence: The forward PE of 11.0x is a 69% discount to the software industry average of 35x, and the trailing PE of 27.0x is near the low end of its 5-year range (18x-48x). Revenue grew 13.3% YoY, and operating margin improved to 21.8% from 19.8% a year ago. TTM free cash flow of $14.66 billion provides a 7.3% yield, supporting the $27 billion buyback plan. The PEG ratio of 1.24 suggests the stock is reasonably priced relative to its growth rate.
Risks & Conditions: The biggest risks are a sustained sector rotation away from software and a potential deceleration in revenue growth below 10%. This Buy rating would be downgraded to Hold if the stock fails to hold above the 52-week low of $146.32 or if revenue growth drops below 10% YoY. It would be upgraded if the stock breaks above the 200-day moving average or if analyst estimates are revised upward. Overall, Salesforce appears undervalued relative to its history and peers, offering a margin of safety for long-term investors.
Sign up to view all
CRM 12-Month Price Forecast
Salesforce's valuation is deeply discounted, and its fundamental trends are improving, but the stock faces significant technical and macro headwinds. The AI assessment is bullish with medium confidence because the risk/reward is skewed to the upside given the low forward PE and strong cash flows. However, the bearish technical trend and sector rotation risk temper conviction. If the stock can hold above $150 and show sustained revenue acceleration, the stance would upgrade to high confidence. Conversely, a break below $146 would force a reassessment.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $245.16 and implied upside of +43.6% versus the current price.
Average Target
$245.16
0 analysts
Implied Upside
+43.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $475
Analyst target range
Salesforce is covered by 52 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.62 (where 1 is Strong Buy and 5 is Sell). The average target price is $245.16, implying approximately 43.5% upside from the current price of $170.77. The distribution leans bullish, with the majority of analysts rating the stock as Buy or Outperform. Recent ratings actions include upgrades from Guggenheim (Neutral to Buy) and a downgrade from Keybanc (Overweight to Sector Weight), indicating some divergence in sentiment. The target price range spans from a low of $160.00 to a high of $475.00, reflecting a wide dispersion of views. The high target of $475.00 assumes a significant recovery in growth and multiple expansion, potentially driven by successful AI monetization and margin improvements. The low target of $160.00, which is below the current price, suggests that some analysts see downside risk from continued spending rotation away from software or execution missteps. The wide spread between low and high targets (315 points) indicates high uncertainty about the stock's future trajectory. The recent downgrade by Keybanc and the upgrade by Guggenheim highlight the lack of consensus, but the overall average target still points to substantial upside, supported by the company's strong fundamentals and attractive valuation.
Drowning in data?
Find the real signal!
Bulls vs Bears: CRM Investment Factors
Salesforce presents a compelling value opportunity with a forward PE of 11.0x, strong margin expansion, and robust free cash flow generation. The analyst consensus is bullish, with an average target implying 43.5% upside. However, the stock is in a sustained downtrend, underperforming the market by over 50% in the past year, and faces headwinds from a sector rotation away from software. The single most important tension is whether the company's improving profitability and AI-driven growth can overcome the macro-driven multiple compression. If the rotation continues, the stock could test its 52-week low of $146.32; if sentiment shifts, the deep value discount could drive a significant rebound. Currently, the bull case has stronger fundamental evidence, but the bearish technical and macro factors cannot be ignored.
Bullish
- Attractive forward valuation: CRM trades at a forward PE of 11.0x, a 69% discount to the software industry average of 35x. This implies the market is pricing in significant skepticism, but if growth and margins hold, the stock offers substantial upside.
- Strong margin expansion trajectory: Operating margin improved to 21.8% in Q1 2027 from 19.8% a year ago, driven by disciplined expense control. Net margin reached 18.9%, up from 15.7% in the prior-year quarter, showing the company's focus on profitability.
- Robust free cash flow generation: TTM free cash flow is $14.66 billion, representing a 7.3% FCF yield on the current market cap. This provides ample capacity for the $27 billion share repurchase plan and strategic investments.
- Analyst consensus bullish with 43.5% upside: The average analyst target price is $245.16, implying 43.5% upside from the current price of $170.77. The consensus recommendation is Buy, with a mean score of 1.62 (1=Strong Buy).
Bearish
- Sustained downtrend and severe underperformance: CRM is down 34.3% over the past year versus the S&P 500's gain of 18.4%, a relative underperformance of -52.6%. The stock trades at 62.3% of its 52-week range, near the low end, indicating persistent selling pressure.
- Sector rotation away from software: Recent news highlights a shift in enterprise tech spending from software to hardware, as evidenced by IBM's weak guidance and a broader selloff in high-multiple software stocks. This macro headwind could continue to pressure CRM's multiple.
- Moderate revenue growth relative to peers: Revenue grew 13.3% YoY in Q1 2027, which is solid but not exceptional compared to high-growth SaaS peers. The PEG ratio of 1.24 suggests the growth rate is already priced in to some extent.
- Wide dispersion in analyst targets: Analyst targets range from $160.00 (below current price) to $475.00, a spread of 315 points. This high uncertainty reflects divergent views on the company's future, with some analysts seeing downside risk.
CRM Technical Analysis
Salesforce is in a sustained downtrend, with the stock price declining 34.3% over the past year and currently trading at 62.3% of its 52-week range (current price $170.77 vs. 52-week low of $146.32 and high of $274.00). The price sits closer to the low end of the range, suggesting the stock is deeply oversold and potentially offering a value opportunity, though the trend remains bearish. The 1-year price change of -34.3% contrasts sharply with the S&P 500's gain of 18.4%, indicating significant underperformance and negative relative strength of -52.6% over the same period. Short-term momentum shows a conflicting signal: the 1-month price change is +10.2%, while the 3-month change is -6.2%, and the 6-month change is -24.8%. This divergence—a positive 1-month return within a longer-term downtrend—could indicate a short-term bounce or mean reversion attempt, but the 3-month and 6-month declines suggest the broader downtrend remains intact. The relative strength over 1 month is +9.9%, outperforming the S&P 500, which may hint at a potential trend reversal if sustained. Key support is at the 52-week low of $146.32, a break below which would signal further downside and potentially accelerate selling. Resistance is at the 52-week high of $274.00, and a breakout above that level would indicate a major trend reversal. The stock's beta of 1.18 implies it is 18% more volatile than the market, meaning it tends to amplify market moves, which is important for risk management. The current price is 16.7% above the 52-week low, providing a near-term support zone, but the stock remains 37.7% below the 52-week high, underscoring the depth of the downtrend.
Beta
1.18
1.18x market volatility
Max Drawdown
-45.1%
Largest decline past year
52-Week Range
$146-$274
Price range past year
Annual Return
-34.3%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | +10.2% | -0.5% |
| 3m | -6.2% | +4.9% |
| 6m | -24.8% | +9.7% |
| 1y | -34.3% | +18.4% |
| ytd | -32.7% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Salesforce's revenue trajectory remains solidly growing, with Q1 2027 (April 30, 2026) revenue of $11.13 billion, up 13.3% year-over-year from $9.83 billion in the prior-year quarter. The multi-quarter trend shows consistent acceleration: Q1 2026 revenue was $9.83 billion, Q2 2026 $10.24 billion, Q3 2026 $10.26 billion, and Q4 2026 $11.20 billion, indicating a steady growth trajectory. The subscription and support segment, which generated $10.59 billion in Q1 2027 (95.1% of total revenue), is the primary growth driver, while professional services contributed $0.54 billion. This growth is driven by the company's expanding customer base and increased adoption of its AI-powered tools, though the pace of growth is moderate relative to high-growth peers. Profitability is robust, with net income of $2.11 billion in Q1 2027, up from $1.54 billion in the prior-year quarter, representing a net margin of 18.9%. Gross margin remains strong at 76.9%, stable over recent quarters (Q4 2026: 77.6%, Q3 2026: 78.0%, Q2 2026: 78.1%), indicating pricing power and efficient cost management. Operating margin improved to 21.8% in Q1 2027 from 19.8% a year ago, reflecting disciplined expense control, particularly in sales and marketing (down to 33.9% of revenue from 34.9% a year ago). The balance sheet is healthy, with a debt-to-equity ratio of 0.29, indicating low leverage. Free cash flow (FCF) for the trailing twelve months (TTM) is $14.66 billion, representing a FCF yield of 7.3% based on the current market cap of $201.7 billion. The company generated $6.70 billion in operating cash flow in Q1 2027, easily covering capital expenditures of $0.15 billion. Return on equity (ROE) stands at 12.6%, reflecting efficient capital allocation. The current ratio of 0.76 is below 1.0, but this is typical for software companies with strong cash generation, and the company has $8.94 billion in cash at the end of Q1 2027.
Quarterly Revenue
$11.1B
2026-04
Revenue YoY Growth
+13.3%
YoY Comparison
Gross Margin
76.9%
Latest Quarter
Free Cash Flow
$14.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Since Salesforce has positive net income, the primary valuation metric is the price-to-earnings (PE) ratio. The trailing PE is 27.0x, while the forward PE is 11.0x, based on estimated EPS of $25.18. The large gap between trailing and forward PE implies the market expects significant earnings growth in the coming year, driven by margin expansion and share buybacks. Compared to the software industry average PE of approximately 35x, Salesforce's trailing PE of 27.0x represents a 23% discount, suggesting the stock is undervalued relative to its peers. However, the forward PE of 11.0x is even more attractive, trading at a 69% discount to the industry forward average of 35x, which may reflect skepticism about the sustainability of growth or concerns about competitive pressures. Historically, Salesforce's trailing PE has ranged from 18x to 48x over the past five years. The current trailing PE of 27.0x is near the lower end of this range, indicating that the stock is trading at a historically low valuation. This could signal a value opportunity if the company's growth and profitability remain strong, but it may also reflect structural challenges such as slowing growth or margin compression. The price-to-sales (PS) ratio of 4.86x is also below the 5-year average of 8x, further supporting the view that the stock is cheap on a historical basis.
PE
27.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~247x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Salesforce's debt-to-equity ratio of 0.29 is low, but the current ratio of 0.76 indicates potential short-term liquidity pressure. The company's revenue growth of 13.3% YoY, while solid, is moderate for a tech stock, and any deceleration could lead to multiple compression. The large gap between trailing PE of 27.0x and forward PE of 11.0x implies the market expects significant earnings growth; if margins fail to expand as anticipated, the stock could re-rate lower. Additionally, the $27 billion share repurchase plan, while bullish, could strain cash if free cash flow declines.
Market & Competitive Risks: CRM's beta of 1.18 makes it 18% more volatile than the market, amplifying downside in selloffs. The stock is trading at a forward PE discount to the industry, but this could be a value trap if the sector rotation from software to hardware persists. Recent news of IBM's weak guidance and a broader tech rotation highlights the risk of continued multiple compression. Competition from Microsoft Dynamics and other CRM players could pressure market share, and the company's high exposure to enterprise spending makes it sensitive to macroeconomic downturns.
Worst-Case Scenario: If the rotation out of software accelerates and CRM's growth decelerates below 10%, the stock could fall to its 52-week low of $146.32, representing a 14.3% decline from the current price of $170.77. In a severe recession, the stock could drop further, potentially testing the $130 level (a 24% decline), based on historical drawdowns. The maximum drawdown over the past year was -45.14%, so a worst-case scenario could see losses of up to 45% from the 52-week high, but from the current price, a 14-24% decline is realistic.
FAQ
The key risks are: 1) Sector rotation risk: enterprise tech spending is shifting from software to hardware, as highlighted by IBM's weak guidance, which could continue to pressure CRM's multiple. 2) Growth deceleration: revenue growth of 13.3% YoY is moderate, and any slowdown below 10% could trigger multiple compression. 3) Technical risk: the stock is in a sustained downtrend, down 34.3% over the past year, and a break below the 52-week low of $146.32 could accelerate selling. 4) Competitive risk: Microsoft Dynamics and other CRM players could erode market share. The most severe risk is a combination of macro headwinds and execution missteps, which could push the stock to $130-146.
The 12-month outlook is balanced but skewed to the upside. The base case (45% probability) sees the stock recovering to $200-245 as the market recognizes the value, driven by steady revenue growth and margin expansion. The bull case (30% probability) targets $245-310, assuming AI-driven adoption and a reversal of the sector rotation. The bear case (25% probability) sees the stock testing $146-170 if growth decelerates and macro headwinds persist. The most likely scenario is the base case, with the stock trending toward the analyst average target of $245.16. Key assumptions include revenue growth of 12-14% and operating margin expansion to 23%.
CRM appears undervalued based on both historical and peer comparisons. The trailing PE of 27.0x is near the low end of its 5-year range (18x-48x), and the forward PE of 11.0x represents a 69% discount to the software industry average of 35x. The price-to-sales ratio of 4.86x is well below the 5-year average of 8x. The market is pricing in significant skepticism about future growth, as evidenced by the large gap between trailing and forward PE. This discount implies that if CRM can maintain its 13% revenue growth and expand margins, the stock offers substantial upside. The PEG ratio of 1.24 suggests the valuation is reasonable relative to its growth rate.
CRM appears to be a good buy for investors with a 12-24 month horizon, given its deeply discounted valuation (forward PE 11.0x vs. industry 35x) and strong free cash flow generation ($14.66 billion TTM). The analyst consensus is Buy with an average target price of $245.16, implying 43.5% upside. However, the stock is in a sustained downtrend and faces headwinds from a sector rotation away from software. The biggest downside risk is a continued shift in enterprise spending to hardware, which could push the stock to its 52-week low of $146.32. For long-term investors willing to tolerate volatility, the risk/reward is favorable; for short-term traders, the technical trend remains bearish.
CRM is better suited for long-term investment (12-24 months or more) due to its deep value discount and strong fundamentals, but near-term volatility is high (beta 1.18). Short-term traders face a bearish technical trend, with the stock down 34.3% over the past year and trading near the low end of its range. However, the 1-month return of +10.2% suggests a potential short-term bounce. For long-term investors, the low forward PE, robust free cash flow, and $27 billion buyback provide a margin of safety. A minimum holding period of 12 months is recommended to allow the thesis to play out. The stock does not pay a meaningful dividend (yield 0.79%), so it is not suitable for income investors.
